Phase 2 Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have read and fully understood the study information and have freely agreed to take part by signing a consent form
- You are between 18 and 75 years old (inclusive)
- You have been diagnosed through a biopsy or tissue test with advanced stomach cancer or cancer at the junction of the stomach and food pipe (a specific type called adenocarcinoma)
- You have not previously received any anti-cancer treatment for your cancer that has spread to other parts of the body
- Your cancer tests positive for a protein called HER2
- You are generally able to carry out daily activities with little or no limitation (a doctor will assess this using a standard scale rated 0–1)
- Your doctors expect you to live for at least 3 months
- You have at least one area of cancer that can be measured on a scan
- Your blood counts and organ function (including your liver, kidneys, and blood cells) meet certain minimum levels — you must not have received blood products or growth factor injections in the 14 days before joining
- If you are a woman who could become pregnant, you are using effective contraception
- You are willing and able to attend follow-up appointments and follow the study plan
Who may not be able to join:
- You are unable or unwilling to follow the study rules and procedures
- You have previously been treated with certain targeted drugs (VEGFR inhibitors), chemotherapy, or immunotherapy
- You have had another type of cancer in the past 5 years — exceptions may apply for certain treated skin cancers or early-stage cervical changes (confirm with trial site)
- You have cancer that has spread to the brain or spinal fluid and is causing symptoms
- You have an autoimmune disease (where your immune system attacks your own body) or have had one in the past 4 weeks
- You have previously had a bone marrow transplant or an organ transplant from another person
- You have a build-up of fluid in your abdomen that cannot be controlled with medication or drainage procedures
- You have had serious heart problems such as unstable chest pain or a heart attack in the past 6 months
- You are known to be allergic to the study drug or any of its ingredients
- You have taken part in another clinical trial using an unapproved drug in the past 4 weeks
- Your blood clotting test results are above a certain level, suggesting a higher risk of bleeding (confirm with trial site)
- You have significant abnormalities in your blood salt (electrolyte) levels, as judged by the doctor
- You have high blood pressure that cannot be controlled with medication (specifically, top number 140 or higher and/or bottom number 90 or higher)
- You have poorly controlled diabetes, even after treatment
- You have a condition that affects how you absorb medication, or you are unable to swallow tablets
- You have active stomach or intestinal problems such as stomach ulcers, bowel inflammation, or a risk of bleeding or a hole forming in the gut
- You have had significant bleeding in the past 3 months, coughed up blood recently, or had a blood clot, stroke, or mini-stroke in the past 12 months
- You have significant heart problems, including recent heart attack, severe chest pain, heart bypass surgery, heart failure above a certain level, irregular heart rhythm needing treatment, or your heart pumping function is below (or above) a certain threshold (confirm with trial site)
- You still have side effects from previous cancer treatment that have not fully resolved (with some exceptions such as hair loss)
- You are pregnant or breastfeeding
- You have received a blood transfusion, blood products, or certain growth factor injections within the past 14 days
- You have protein showing up in your urine above a certain level
- You need long-term use of drugs that suppress the immune system, or steroid medications above a low daily dose
- You have any other medical condition that the doctor believes makes it unsafe or unsuitable for you to take part
- The study doctor has any other concern that makes you unsuitable for the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Huifang Lv, Henan Cancer Hospital (Affiliated Cancer Hospital of Zhengzhou University)
Phone: 8618639027635
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Recommended Phase 2 doses (RP2Ds); PFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.